1 Study Coverage 1.1 Immune Checkpoint Blockers Product Introduction 1.2 Market by Type 1.2.1 Global Immune Checkpoint Blockers Market Size Growth Rate by Type 1.2.2 Anti-PD-L1 Drug 1.2.3 Anti-PD-1 Drug 1.2.4 CTLA4 1.3 Market by Application 1.3.1 Global Immune Checkpoint Blockers Market Size Growth Rate by Application 1.3.2 Lung Cancer 1.3.3 Colorectal Cancer 1.3.4 BreastCancer 1.3.5 Prostate Cancer 1.3.6 Melanoma 1.3.7 Blood Cancers 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Immune Checkpoint Blockers Market Size, Estimates and Forecasts 2.1.1 Global Immune Checkpoint Blockers Revenue 2016-2027 2.1.2 Global Immune Checkpoint Blockers Sales 2016-2027 2.2 Global Immune Checkpoint Blockers, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Immune Checkpoint Blockers Historical Market Size by Region (2016-2021) 2.3.1 Global Immune Checkpoint Blockers Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Immune Checkpoint Blockers Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Immune Checkpoint Blockers Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Immune Checkpoint Blockers Sales Forecast by Region (2022-2027) 2.4.2 Global Immune Checkpoint Blockers Revenue Forecast by Region (2022-2027) 3 Global Immune Checkpoint Blockers Competitor Landscape by Players 3.1 Global Top Immune Checkpoint Blockers Manufacturers by Sales 3.1.1 Global Immune Checkpoint Blockers Sales by Manufacturer (2016-2021) 3.1.2 Global Immune Checkpoint Blockers Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Immune Checkpoint Blockers Manufacturers by Revenue 3.2.1 Key Immune Checkpoint Blockers Manufacturers Covered: Ranking by Revenue 3.2.2 Global Immune Checkpoint Blockers Revenue by Manufacturers (2016-2021) 3.2.3 Global Immune Checkpoint Blockers Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Immune Checkpoint Blockers Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Immune Checkpoint Blockers Revenue in 2020 3.2.6 Global Immune Checkpoint Blockers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Immune Checkpoint Blockers Price by Manufacturers 3.4 Global Immune Checkpoint Blockers Manufacturing Base Distribution, Product Types 3.4.1 Immune Checkpoint Blockers Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Immune Checkpoint Blockers Product Type 3.4.3 Date of International Manufacturers Enter into Immune Checkpoint Blockers Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Immune Checkpoint Blockers Market Size by Type (2016-2021) 4.1.1 Global Immune Checkpoint Blockers Sales by Type (2016-2021) 4.1.2 Global Immune Checkpoint Blockers Revenue by Type (2016-2021) 4.1.3 Immune Checkpoint Blockers Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Immune Checkpoint Blockers Market Size Forecast by Type (2022-2027) 4.2.1 Global Immune Checkpoint Blockers Sales Forecast by Type (2022-2027) 4.2.2 Global Immune Checkpoint Blockers Revenue Forecast by Type (2022-2027) 4.2.3 Immune Checkpoint Blockers Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Immune Checkpoint Blockers Market Size by Application (2016-2021) 5.1.1 Global Immune Checkpoint Blockers Sales by Application (2016-2021) 5.1.2 Global Immune Checkpoint Blockers Revenue by Application (2016-2021) 5.1.3 Immune Checkpoint Blockers Price by Application (2016-2021) 5.2 Immune Checkpoint Blockers Market Size Forecast by Application (2022-2027) 5.2.1 Global Immune Checkpoint Blockers Sales Forecast by Application (2022-2027) 5.2.2 Global Immune Checkpoint Blockers Revenue Forecast by Application (2022-2027) 5.2.3 Global Immune Checkpoint Blockers Price Forecast by Application (2022-2027) 6 United States by Players, Type and Application 6.1 United States Immune Checkpoint Blockers Market Size YoY Growth 2016-2027 6.1.1 United States Immune Checkpoint Blockers Sales YoY Growth 2016-2027 6.1.2 United States Immune Checkpoint Blockers Revenue YoY Growth 2016-2027 6.1.3 United States Immune Checkpoint Blockers Market Share in Global Market 2016-2027 6.2 United States Immune Checkpoint Blockers Market Size by Players (International and Local Players) 6.2.1 United States Top Immune Checkpoint Blockers Players by Sales (2016-2021) 6.2.2 United States Top Immune Checkpoint Blockers Players by Revenue (2016-2021) 6.3 United States Immune Checkpoint Blockers Historic Market Review by Type (2016-2021) 6.3.1 United States Immune Checkpoint Blockers Sales Market Share by Type (2016-2021) 6.3.2 United States Immune Checkpoint Blockers Revenue Market Share by Type (2016-2021) 6.3.3 United States Immune Checkpoint Blockers Price by Type (2016-2021) 6.4 United States Immune Checkpoint Blockers Market Estimates and Forecasts by Type (2022-2027) 6.4.1 United States Immune Checkpoint Blockers Sales Forecast by Type (2022-2027) 6.4.2 United States Immune Checkpoint Blockers Revenue Forecast by Type (2022-2027) 6.4.3 United States Immune Checkpoint Blockers Price Forecast by Type (2022-2027) 6.5 United States Immune Checkpoint Blockers Historic Market Review by Application (2016-2021) 6.5.1 United States Immune Checkpoint Blockers Sales Market Share by Application (2016-2021) 6.5.2 United States Immune Checkpoint Blockers Revenue Market Share by Application (2016-2021) 6.5.3 United States Immune Checkpoint Blockers Price by Application (2016-2021) 6.6 United States Immune Checkpoint Blockers Market Estimates and Forecasts by Application (2022-2027) 6.6.1 United States Immune Checkpoint Blockers Sales Forecast by Application (2022-2027) 6.6.2 United States Immune Checkpoint Blockers Revenue Forecast by Application (2022-2027) 6.6.3 United States Immune Checkpoint Blockers Price Forecast by Application (2022-2027) 7 North America 7.1 North America Immune Checkpoint Blockers Market Size YoY Growth 2016-2027 7.2 North America Immune Checkpoint Blockers Market Facts & Figures by Country 7.2.1 North America Immune Checkpoint Blockers Sales by Country (2016-2021) 7.2.2 North America Immune Checkpoint Blockers Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Immune Checkpoint Blockers Market Size YoY Growth 2016-2027 8.2 Asia Pacific Immune Checkpoint Blockers Market Facts & Figures by Region 8.2.1 Asia Pacific Immune Checkpoint Blockers Sales by Region (2016-2021) 8.2.2 Asia Pacific Immune Checkpoint Blockers Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Immune Checkpoint Blockers Market Size YoY Growth 2016-2027 9.2 Europe Immune Checkpoint Blockers Market Facts & Figures by Country 9.2.1 Europe Immune Checkpoint Blockers Sales by Country (2016-2021) 9.2.2 Europe Immune Checkpoint Blockers Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Immune Checkpoint Blockers Market Size YoY Growth 2016-2027 10.2 Latin America Immune Checkpoint Blockers Market Facts & Figures by Country 10.2.1 Latin America Immune Checkpoint Blockers Sales by Country (2016-2021) 10.2.2 Latin America Immune Checkpoint Blockers Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Immune Checkpoint Blockers Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Immune Checkpoint Blockers Market Facts & Figures by Country 11.2.1 Middle East and Africa Immune Checkpoint Blockers Sales by Country (2016-2021) 11.2.2 Middle East and Africa Immune Checkpoint Blockers Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 U.A.E 12 Company Profiles 12.1 Bristol Myers Squibb 12.1.1 Bristol Myers Squibb Corporation Information 12.1.2 Bristol Myers Squibb Description and Business Overview 12.1.3 Bristol Myers Squibb Immune Checkpoint Blockers Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Bristol Myers Squibb Immune Checkpoint Blockers Products Offered 12.1.5 Bristol Myers Squibb Recent Development 12.2 Merck 12.2.1 Merck Corporation Information 12.2.2 Merck Description and Business Overview 12.2.3 Merck Immune Checkpoint Blockers Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Merck Immune Checkpoint Blockers Products Offered 12.2.5 Merck Recent Development 12.3 AstraZeneca 12.3.1 AstraZeneca Corporation Information 12.3.2 AstraZeneca Description and Business Overview 12.3.3 AstraZeneca Immune Checkpoint Blockers Sales, Revenue and Gross Margin (2016-2021) 12.3.4 AstraZeneca Immune Checkpoint Blockers Products Offered 12.3.5 AstraZeneca Recent Development 12.4 Roche 12.4.1 Roche Corporation Information 12.4.2 Roche Description and Business Overview 12.4.3 Roche Immune Checkpoint Blockers Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Roche Immune Checkpoint Blockers Products Offered 12.4.5 Roche Recent Development 12.11 Bristol Myers Squibb 12.11.1 Bristol Myers Squibb Corporation Information 12.11.2 Bristol Myers Squibb Description and Business Overview 12.11.3 Bristol Myers Squibb Immune Checkpoint Blockers Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Bristol Myers Squibb Immune Checkpoint Blockers Products Offered 12.11.5 Bristol Myers Squibb Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Immune Checkpoint Blockers Industry Trends 13.2 Immune Checkpoint Blockers Market Drivers 13.3 Immune Checkpoint Blockers Market Challenges 13.4 Immune Checkpoint Blockers Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Immune Checkpoint Blockers Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Immune Checkpoint Blockers Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Anti-PD-L1 Drug Table 3. Major Manufacturers of Anti-PD-1 Drug Table 4. Major Manufacturers of CTLA4 Table 5. Global Immune Checkpoint Blockers Market Size Growth Rate by Application (2021-2027) & (K Units) Table 6. Global Immune Checkpoint Blockers Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027 Table 7. Global Immune Checkpoint Blockers Sales by Regions (2016-2021) & (K Units) Table 8. Global Immune Checkpoint Blockers Sales Market Share by Regions (2016-2021) Table 9. Global Immune Checkpoint Blockers Revenue by Regions (2016-2021) & (US$ Million) Table 10. Global Immune Checkpoint Blockers Sales Forecast by Region (2022-2027) & (K Units) Table 11. Global Immune Checkpoint Blockers Sales Market Share Forecast by Region (2022-2027) Table 12. Global Immune Checkpoint Blockers Revenue Forecast by Region (2022-2027) & (US$ Million) Table 13. Global Immune Checkpoint Blockers Revenue Market Share Forecast by Region (2022-2027) Table 14. Global Immune Checkpoint Blockers Sales by Manufacturers (2016-2021) (K Units) Table 15. Global Immune Checkpoint Blockers Sales Share by Manufacturers (2016-2021) Table 16. Ranking of Global Top Immune Checkpoint Blockers Manufacturers by Revenue (US$ Million) in 2020 Table 17. Immune Checkpoint Blockers Revenue by Manufacturers (2016-2021) (US$ Million) Table 18. Immune Checkpoint Blockers Revenue Share by Manufacturers (2016-2021) Table 19. Global Immune Checkpoint Blockers Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 20. Global Immune Checkpoint Blockers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immune Checkpoint Blockers as of 2020) Table 21. Key Manufacturers Immune Checkpoint Blockers Price (2016-2021) (USD/Unit) Table 22. Immune Checkpoint Blockers Manufacturers Manufacturing Base Distribution and Headquarters Table 23. Manufacturers Immune Checkpoint Blockers Product Type Table 24. Date of International Manufacturers Enter into Immune Checkpoint Blockers Market Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans Table 26. Global Immune Checkpoint Blockers Sales by Type (2016-2021) (K Units) Table 27. Global Immune Checkpoint Blockers Sales Share by Type (2016-2021) Table 28. Global Immune Checkpoint Blockers Revenue by Type (2016-2021) (US$ Million) Table 29. Global Immune Checkpoint Blockers Revenue Share by Type (2016-2021) Table 30. Immune Checkpoint Blockers Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit) Table 31. Global Immune Checkpoint Blockers Sales Forecast by Type (2022-2027) & (K Units) Table 32. Global Immune Checkpoint Blockers Sales Market Share Forecast by Type (2022-2027) Table 33. Global Immune Checkpoint Blockers Revenue Forecast V (2022-2027) & (US$ Million) Table 34. Global Immune Checkpoint Blockers Revenue Market Share Forecast by Type (2022-2027) Table 35. Global Immune Checkpoint Blockers Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit) Table 36. Global Immune Checkpoint Blockers Sales by Application (2016-2021) (K Units) Table 37. Global Immune Checkpoint Blockers Sales Share by Application (2016-2021) Table 38. Global Immune Checkpoint Blockers Revenue by Application (2016-2021) (US$ Million) Table 39. Global Immune Checkpoint Blockers Revenue Share by Application (2016-2021) Table 40. Immune Checkpoint Blockers Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit) Table 41. Global Immune Checkpoint Blockers Sales Forecast by Application (2022-2027) & (K Units) Table 42. Global Immune Checkpoint Blockers Sales Market Share Forecast by Application (2022-2027) Table 43. Global Immune Checkpoint Blockers Revenue Forecast by Application (2022-2027) & (US$ Million) Table 44. Global Immune Checkpoint Blockers Revenue Market Share Forecast by Application (2022-2027) Table 45. Global Immune Checkpoint Blockers Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit) Table 46. United States Immune Checkpoint Blockers Sales (K Units) of Key Companies (2016-2021) Table 47. United States Immune Checkpoint Blockers Sales Share by Company (2016-2021) Table 48. United States Immune Checkpoint Blockers Revenue (US$ Million) by Company (2016-2021) Table 49. United States Immune Checkpoint Blockers Revenue Share by Company (2016-2021) Table 50. United States Immune Checkpoint Blockers Sales (K Units) by Type (2016-2021) Table 51. United States Immune Checkpoint Blockers Sales Share by Type (2016-2021) Table 52. United States Immune Checkpoint Blockers Revenue (US$ Million) Market Share by Type (2016-2021) Table 53. United States Immune Checkpoint Blockers Price (USD/Unit) by Type (2016-2021) Table 54. United States Immune Checkpoint Blockers Sales (K Units) by Type (2022-2027) Table 55. United States Immune Checkpoint Blockers Sales Share by Type (2022-2027) Table 56. United States Immune Checkpoint Blockers Revenue (US$ Million) Market Share by Type (2022-2027) Table 57. United States Immune Checkpoint Blockers Revenue Share by Type (2022-2027) Table 58. United States Immune Checkpoint Blockers Price (USD/Unit) by Type (2022-2027) Table 59. United States Immune Checkpoint Blockers Sales (K Units) by Application (2016-2021) Table 60. United States Immune Checkpoint Blockers Sales Share by Application (2016-2021) Table 61. United States Immune Checkpoint Blockers Revenue (US$ Million) Market Share by Application (2016-2021) Table 62. United States Immune Checkpoint Blockers Price (USD/Unit) by Application (2016-2021) Table 63. United States Immune Checkpoint Blockers Sales (K Units) by Application (2022-2027) Table 64. United States Immune Checkpoint Blockers Sales Share by Application (2022-2027) Table 65. United States Immune Checkpoint Blockers Revenue (US$ Million) Market Share by Application (2022-2027) Table 66. United States Immune Checkpoint Blockers Revenue Share by Application (2022-2027) Table 67. United States Immune Checkpoint Blockers Price (USD/Unit) by Application (2022-2027) Table 68. North America Immune Checkpoint Blockers Sales by Country (2016-2021) & (K Units) Table 69. North America Immune Checkpoint Blockers Sales Market Share by Country (2016-2021) Table 70. North America Immune Checkpoint Blockers Revenue by Country (2016-2021) & (US$ Million) Table 71. North America Immune Checkpoint Blockers Revenue Market Share by Country (2016-2021) Table 72. Asia Pacific Immune Checkpoint Blockers Sales by Region (2016-2021) & (K Units) Table 73. Asia Pacific Immune Checkpoint Blockers Sales Market Share by Region (2016-2021) Table 74. Asia Pacific Immune Checkpoint Blockers Revenue by Region (2016-2021) & (US$ Million) Table 75. Asia Pacific Immune Checkpoint Blockers Revenue Market Share by Region (2016-2021) Table 76. Europe Immune Checkpoint Blockers Sales by Country (2016-2021) & (K Units) Table 77. Europe Immune Checkpoint Blockers Sales Market Share by Country (2016-2021) Table 78. Europe Immune Checkpoint Blockers Revenue by Country (2016-2021) & (US$ Million) Table 79. Europe Immune Checkpoint Blockers Revenue Market Share by Country (2016-2021) Table 80. Latin America Immune Checkpoint Blockers Sales by Country (2016-2021) & (K Units) Table 81. Latin America Immune Checkpoint Blockers Sales Market Share by Country (2016-2021) Table 82. Latin Americaa Immune Checkpoint Blockers Revenue by Country (2016-2021) & (US$ Million) Table 83. Latin America Immune Checkpoint Blockers Revenue Market Share by Country (2016-2021) Table 84. Middle East and Africa Immune Checkpoint Blockers Sales by Country (2016-2021) & (K Units) Table 85. Middle East and Africa Immune Checkpoint Blockers Sales Market Share by Country (2016-2021) Table 86. Middle East and Africa Immune Checkpoint Blockers Revenue by Country (2016-2021) & (US$ Million) Table 87. Middle East and Africa Immune Checkpoint Blockers Revenue Market Share by Country (2016-2021) Table 88. Bristol Myers Squibb Corporation Information Table 89. Bristol Myers Squibb Description and Business Overview Table 90. Bristol Myers Squibb Immune Checkpoint Blockers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 91. Bristol Myers Squibb Immune Checkpoint Blockers Product Table 92. Bristol Myers Squibb Recent Development Table 93. Merck Corporation Information Table 94. Merck Description and Business Overview Table 95. Merck Immune Checkpoint Blockers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 96. Merck Product Table 97. Merck Recent Development Table 98. AstraZeneca Corporation Information Table 99. AstraZeneca Description and Business Overview Table 100. AstraZeneca Immune Checkpoint Blockers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 101. AstraZeneca Product Table 102. AstraZeneca Recent Development Table 103. Roche Corporation Information Table 104. Roche Description and Business Overview Table 105. Roche Immune Checkpoint Blockers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 106. Roche Product Table 107. Roche Recent Development Table 108. Immune Checkpoint Blockers Market Trends Table 109. Immune Checkpoint Blockers Market Drivers Table 110. Immune Checkpoint Blockers Market Challenges Table 111. Immune Checkpoint Blockers Market Restraints Table 112. Immune Checkpoint Blockers Customers List Table 113. Immune Checkpoint Blockers Distributors List Table 114. Research Programs/Design for This Report Table 115. Key Data Information from Secondary Sources Table 116. Key Data Information from Primary Sources List of Figures Figure 1. Immune Checkpoint Blockers Product Picture Figure 2. Global Immune Checkpoint Blockers Sales Market Share by Type in 2020 & 2027 Figure 3. Anti-PD-L1 Drug Product Picture Figure 4. Anti-PD-1 Drug Product Picture Figure 5. CTLA4 Product Picture Figure 6. Global Immune Checkpoint Blockers Sales Market Share by Application in 2020 & 2027 Figure 7. Lung Cancer Figure 8. Colorectal Cancer Figure 9. BreastCancer Figure 10. Prostate Cancer Figure 11. Melanoma Figure 12. Blood Cancers Figure 13. Immune Checkpoint Blockers Report Years Considered Figure 14. Global Immune Checkpoint Blockers Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 15. Global Immune Checkpoint Blockers Market Size 2016-2027 (US$ Million) Figure 16. Global Immune Checkpoint Blockers Sales 2016-2027 (K Units) Figure 17. Global Immune Checkpoint Blockers Market Size Market Share by Region: 2021 Versus 2027 Figure 18. Global Immune Checkpoint Blockers Sales Market Share by Region (2016-2021) Figure 19. Global Immune Checkpoint Blockers Sales Market Share by Region in 2020 Figure 20. Global Immune Checkpoint Blockers Revenue Market Share by Region (2016-2021) Figure 21. Global Immune Checkpoint Blockers Revenue Market Share by Region in 2020 Figure 22. Global Immune Checkpoint Blockers Sales Share by Manufacturer in 2020 Figure 23. The Top 10 and 5 Players Market Share by Immune Checkpoint Blockers Revenue in 2020 Figure 24. Immune Checkpoint Blockers Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 25. Global Immune Checkpoint Blockers Sales Market Share by Type (2016-2021) Figure 26. Global Immune Checkpoint Blockers Sales Market Share by Type in 2020 Figure 27. Global Immune Checkpoint Blockers Revenue Market Share by Type (2016-2021) Figure 28. Global Immune Checkpoint Blockers Revenue Market Share by Type in 2020 Figure 29. Global Immune Checkpoint Blockers Sales Market Share by Application (2016-2021) Figure 30. Global Immune Checkpoint Blockers Sales Market Share by Application in 2020 Figure 31. Global Immune Checkpoint Blockers Revenue Market Share by Application (2016-2021) Figure 32. Global Immune Checkpoint Blockers Revenue Market Share by Application in 2020 Figure 33. United States Immune Checkpoint Blockers Sales Growth Rate 2016-2027 (K Units) Figure 34. United States Immune Checkpoint Blockers Revenue Growth Rate 2016-2027 (US$ Million) Figure 35. United States Immune Checkpoint Blockers Market Share in Global Market 2016-2027 Figure 36. United States 5 and 10 Largest Immune Checkpoint Blockers Players Market Share by Revenue in Immune Checkpoint Blockers in 2020 Figure 37. United States Immune Checkpoint Blockers Revenue Share by Type (2016-2021) Figure 38. United States Immune Checkpoint Blockers Revenue Growth Rate by Type in 2016 & 2020 Figure 39. United States Immune Checkpoint Blockers Revenue Share by Application (2016-2021) Figure 40. United States Immune Checkpoint Blockers Revenue Growth Rate by Application in 2016 & 2020 Figure 41. North America Immune Checkpoint Blockers Sales Growth Rate 2016-2021 (K Units) Figure 42. North America Immune Checkpoint Blockers Revenue Growth Rate 2016-2021 (US$ Million) Figure 43. North America Immune Checkpoint Blockers Sales Market Share by Country in 2020 Figure 44. North America Immune Checkpoint Blockers Revenue Market Share by Country in 2020 Figure 45. U.S. Immune Checkpoint Blockers Sales Growth Rate (2016-2021) (K Units) Figure 46. U.S. Immune Checkpoint Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Canada Immune Checkpoint Blockers Sales Growth Rate (2016-2021) (K Units) Figure 48. Canada Immune Checkpoint Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 49. Europe Immune Checkpoint Blockers Sales Growth Rate 2016-2021 (K Units) Figure 50. Europe Immune Checkpoint Blockers Revenue Growth Rate 2016-2021 (US$ Million) Figure 51. Europe Immune Checkpoint Blockers Sales Market Share by Country in 2020 Figure 52. Europe Immune Checkpoint Blockers Revenue Market Share by Country in 2020 Figure 53. Germany Immune Checkpoint Blockers Sales Growth Rate (2016-2021) (K Units) Figure 54. Germany Immune Checkpoint Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 55. France Immune Checkpoint Blockers Sales Growth Rate (2016-2021) (K Units) Figure 56. France Immune Checkpoint Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 57. U.K. Immune Checkpoint Blockers Sales Growth Rate (2016-2021) (K Units) Figure 58. U.K. Immune Checkpoint Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 59. Italy Immune Checkpoint Blockers Sales Growth Rate (2016-2021) (K Units) Figure 60. Italy Immune Checkpoint Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 61. Russia Immune Checkpoint Blockers Sales Growth Rate (2016-2021) (K Units) Figure 62. Russia Immune Checkpoint Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 63. Asia Pacific Immune Checkpoint Blockers Sales Growth Rate 2016-2021 (K Units) Figure 64. Asia Pacific Immune Checkpoint Blockers Revenue Growth Rate 2016-2021 (US$ Million) Figure 65. Asia Pacific Immune Checkpoint Blockers Sales Market Share by Region in 2020 Figure 66. Asia Pacific Immune Checkpoint Blockers Revenue Market Share by Region in 2020 Figure 67. China Immune Checkpoint Blockers Sales Growth Rate (2016-2021) (K Units) Figure 68. China Immune Checkpoint Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 69. Japan Immune Checkpoint Blockers Sales Growth Rate (2016-2021) (K Units) Figure 70. Japan Immune Checkpoint Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 71. South Korea Immune Checkpoint Blockers Sales Growth Rate (2016-2021) (K Units) Figure 72. South Korea Immune Checkpoint Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 73. India Immune Checkpoint Blockers Sales Growth Rate (2016-2021) (K Units) Figure 74. India Immune Checkpoint Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 75. Australia Immune Checkpoint Blockers Sales Growth Rate (2016-2021) (K Units) Figure 76. Australia Immune Checkpoint Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 77. Taiwan Immune Checkpoint Blockers Sales Growth Rate (2016-2021) (K Units) Figure 78. Taiwan Immune Checkpoint Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 79. Indonesia Immune Checkpoint Blockers Sales Growth Rate (2016-2021) (K Units) Figure 80. Indonesia Immune Checkpoint Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 81. Thailand Immune Checkpoint Blockers Sales Growth Rate (2016-2021) (K Units) Figure 82. Thailand Immune Checkpoint Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 83. Malaysia Immune Checkpoint Blockers Sales Growth Rate (2016-2021) (K Units) Figure 84. Malaysia Immune Checkpoint Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 85. Philippines Immune Checkpoint Blockers Sales Growth Rate (2016-2021) (K Units) Figure 86. Philippines Immune Checkpoint Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 87. Vietnam Immune Checkpoint Blockers Sales Growth Rate (2016-2021) (K Units) Figure 88. Vietnam Immune Checkpoint Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 89. Latin America Immune Checkpoint Blockers Sales Growth Rate 2016-2021 (K Units) Figure 90. Latin America Immune Checkpoint Blockers Revenue Growth Rate 2016-2021 (US$ Million) Figure 91. Latin America Immune Checkpoint Blockers Sales Market Share by Country in 2020 Figure 92. Latin America Immune Checkpoint Blockers Revenue Market Share by Country in 2020 Figure 93. Mexico Immune Checkpoint Blockers Sales Growth Rate (2016-2021) (K Units) Figure 94. Mexico Immune Checkpoint Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 95. Brazil Immune Checkpoint Blockers Sales Growth Rate (2016-2021) (K Units) Figure 96. Brazil Immune Checkpoint Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 97. Argentina Immune Checkpoint Blockers Sales Growth Rate (2016-2021) (K Units) Figure 98. Argentina Immune Checkpoint Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 99. Middle East and Africa Immune Checkpoint Blockers Sales Growth Rate 2016-2021 (K Units) Figure 100. Middle East and Africa Immune Checkpoint Blockers Revenue Growth Rate 2016-2021 (US$ Million) Figure 101. Middle East and Africa Immune Checkpoint Blockers Sales Market Share by Country in 2020 Figure 102. Middle East and Africa Immune Checkpoint Blockers Revenue Market Share by Country in 2020 Figure 103. Turkey Immune Checkpoint Blockers Sales Growth Rate (2016-2021) (K Units) Figure 104. Turkey Immune Checkpoint Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 105. Saudi Arabia Immune Checkpoint Blockers Sales Growth Rate (2016-2021) (K Units) Figure 106. Saudi Arabia Immune Checkpoint Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 107. U.A.E Immune Checkpoint Blockers Sales Growth Rate (2016-2021) (K Units) Figure 108. U.A.E Immune Checkpoint Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 109. Immune Checkpoint Blockers Value Chain Figure 110. Channels of Distribution Figure 111. Distributors Profiles Figure 112. Bottom-up and Top-down Approaches for This Report Figure 113. Data Triangulation Figure 114. Key Executives Interviewed

Bristol Myers Squibb Merck AstraZeneca Roche